Get the Stockscreener App
0.576
5.11%
0.028
After Hours:
.58
0.004
+0.69%
Athira Pharma Inc Stock (ATHA) Forecast
The Athira Pharma Inc (ATHA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.6451, representing a +1,054% increase from the current price of $0.576. The highest analyst price target is $9.8379, and the lowest is $3.4524.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATHA Price Target
Average 5.0002
(+768.09% Upside)
Is Athira Pharma Inc (ATHA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.88 | Neutral |
| STOCH(9,6) | 21.08 | Neutral |
| STOCHRSI(14) | 56.78 | Neutral |
| MACD(12,26) | -0.0201 | Sell |
| ADX(14) | 17.59 | Neutral |
| William %R | -62.14 | Neutral |
| CCI(14) | -88.92 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5846
Sell
|
0.5825
Sell
|
| MA20 |
0.6101
Sell
|
0.5999
Sell
|
| MA50 |
0.5877
Sell
|
0.7024
Sell
|
| MA100 |
1.1402
Sell
|
1.0674
Sell
|
| MA200 |
1.8551
Sell
|
1.5394
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ATHA could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ATHA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.88 indicates that ATHA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 21.08 indicates that ATHA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.78 indicates that ATHA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.59 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.92 indicates that ATHA is still oversold but not to an extreme extent.
Long-term ATHA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Athira Pharma Inc financial reports and earnings history, Athira Pharma Inc (ATHA) stock could reach $11.57 by 2030, $14.03 by 2040 and $68.74 by 2050. See the projected annual prices until 2050 of the Athira Pharma Inc stock below:
- Athira Pharma Inc (ATHA) is expected to reach an average price of $17.11 in 2035, with a high prediction of $18.39 and a low estimate of $17.29. This indicates an $2,871% rise from the last recorded price of $0.576.
- Athira Pharma Inc (ATHA) stock is projected to chart a bullish course in 2040, with an average price target of $13.45, representing an $2,236% surge from its current level. The forecast ranges from a conservative $13.54 to a sky-high $14.03.
- Our analysts predict Athira Pharma Inc (ATHA) to jump 11,761% by 2045, soaring from $69.10 to an average price of $68.32, potentially reaching $68.35. While $69.10 is the low estimate, the potential upside is significant.
- Athira Pharma Inc (ATHA) stock is expected to climb by 2050, reaching an average of $68.17, a $11,735% jump from its current level. However, a wide range of estimates exists, with high and low targets of $68.74 and $69.42, respectively, highlighting the market's uncertainty.
Athira Pharma Inc Stock (ATHA) Year by Year Forecast
Athira Pharma Inc Stock (ATHA) Price Forecast for 2025
Athira Pharma Inc Stock (ATHA) is expected to reach an average price of $5.0002 in 2025, with a high prediction of $9.8379 and a low estimate of $0.1626. This indicates an +768.09% rise from the last recorded price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.898 | $3.4524 | $9.8379 | +923.95% |
| February, 2025 | $2.9865 | $3.3564 | $6.3767 | +418.48% |
| March, 2025 | $3.6409 | $3.6276 | $2.7109 | +532.10% |
| April, 2025 | $2.3164 | $2.5864 | $3.1042 | +302.16% |
| May, 2025 | $3.1009 | $2.1686 | $2.5305 | +438.34% |
| June, 2025 | $2.7853 | $3.2253 | $2.9531 | +383.56% |
| July, 2025 | $2.5492 | $0.7014 | $4.6313 | +342.57% |
| August, 2025 | $1.8148 | $0.2059 | $2.9781 | +215.06% |
| September, 2025 | $0.5503 | $0.1626 | $2.4203 | -4.46% |
| October, 2025 | $1.4752 | $0.6108 | $0.8092 | +156.11% |
| November, 2025 | $1.6796 | $1.4963 | $1.5596 | +191.60% |
| December, 2025 | $3.0048 | $0.554 | $3.5748 | +421.67% |
Athira Pharma Inc Stock (ATHA) Price Forecast for 2026
The predicted value for Athira Pharma Inc (ATHA) in 2026 is set at an average of $3.3237. Estimates vary from a peak of $6.3517 to a trough of $0.2957, indicating an +477.03% surge from the present price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2204 | $0.8704 | $3.8626 | +111.88% |
| February, 2026 | $1.014 | $0.2957 | $1.5393 | +76.04% |
| March, 2026 | $1.5084 | $0.9973 | $0.4462 | +161.88% |
| April, 2026 | $5.564 | $1.7895 | $6.3517 | +865.97% |
| May, 2026 | $5.2684 | $5.774 | $5.5862 | +814.65% |
| June, 2026 | $5.3928 | $5.2306 | $5.3328 | +836.25% |
| July, 2026 | $5.4583 | $5.2661 | $5.2798 | +847.63% |
| August, 2026 | $4.7928 | $4.9028 | $5.1395 | +732.08% |
| September, 2026 | $4.8183 | $4.8039 | $4.7146 | +736.51% |
| October, 2026 | $4.3727 | $4.5604 | $4.6194 | +659.15% |
| November, 2026 | $3.4072 | $4.0072 | $4.3138 | +491.52% |
| December, 2026 | $3.5427 | $3.1905 | $3.2583 | +515.05% |
Athira Pharma Inc Stock (ATHA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Athira Pharma Inc (ATHA) is $2.4859, with a high forecast of $3.7716 and a low forecast of $1.2002. This indicates an +331.58% increase from the last price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.5071 | $3.656 | $3.5153 | +508.87% |
| February, 2027 | $3.8615 | $3.9582 | $3.7716 | +570.41% |
| March, 2027 | $3.0571 | $3.2471 | $3.7426 | +430.74% |
| April, 2027 | $2.9715 | $3.1065 | $2.9415 | +415.88% |
| May, 2027 | $2.5259 | $2.6437 | $2.6526 | +338.53% |
| June, 2027 | $2.2615 | $2.1803 | $2.3881 | +292.61% |
| July, 2027 | $2.2959 | $2.1148 | $2.1226 | +298.59% |
| August, 2027 | $2.5503 | $2.3992 | $2.3292 | +342.76% |
| September, 2027 | $2.4358 | $2.4925 | $2.3314 | +322.89% |
| October, 2027 | $2.3303 | $2.4203 | $2.4391 | +304.56% |
| November, 2027 | $2.2347 | $2.2747 | $2.2114 | +287.97% |
| December, 2027 | $0.9002 | $1.2002 | $2.0958 | +56.29% |
Athira Pharma Inc Stock (ATHA) Price Forecast for 2028
In 2028, Athira Pharma Inc (ATHA) is projected to reach an average price of $7.4145, with a high projection of $14.81 and a low estimate of $0.0146. This indicates an +1,187% rise from the last price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0354 | $0.1846 | $0.2654 | -93.86% |
| February, 2028 | $0.8009 | $0.0542 | $1.0659 | +39.05% |
| March, 2028 | $0.1854 | $0.0146 | $1.7065 | -67.81% |
| April, 2028 | $0.281 | $0.1571 | $0.566 | -51.22% |
| May, 2028 | $14.38 | $0.0423 | $13.04 | +2,397% |
| June, 2028 | $14.23 | $15.25 | $14.81 | +2,370% |
| July, 2028 | $7.7277 | $9.2077 | $6.4177 | +1,242% |
| August, 2028 | $0.4812 | $1.3688 | $6.6199 | -16.45% |
| September, 2028 | $10.44 | $0.911 | $4.1676 | +1,712% |
| October, 2028 | $8.4265 | $8.9343 | $7.6298 | +1,363% |
| November, 2028 | $11.17 | $10.24 | $9.3775 | +1,839% |
| December, 2028 | $12.11 | $10.40 | $10.58 | +2,002% |
Athira Pharma Inc Stock (ATHA) Price Forecast for 2029
The 2029 price forecast for Athira Pharma Inc Stock (ATHA) is $12.30 on average, with a high prediction of $16.40 and a low estimate of $8.1991. This represents an +2,036% increase from the previous price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.6674 | $10.38 | $9.5686 | +1,405% |
| February, 2029 | $16.32 | $8.1991 | $7.7067 | +2,733% |
| March, 2029 | $16.03 | $16.88 | $16.40 | +2,682% |
| April, 2029 | $16.40 | $16.91 | $15.96 | +2,748% |
| May, 2029 | $15.02 | $15.18 | $16.15 | +2,507% |
| June, 2029 | $15.74 | $14.94 | $15.22 | +2,633% |
| July, 2029 | $13.89 | $15.22 | $15.45 | +2,312% |
| August, 2029 | $9.9438 | $9.4744 | $11.15 | +1,626% |
| September, 2029 | $11.04 | $10.86 | $9.7183 | +1,817% |
| October, 2029 | $12.64 | $10.99 | $11.55 | +2,095% |
| November, 2029 | $11.99 | $12.47 | $11.85 | +1,982% |
| December, 2029 | $12.37 | $12.69 | $12.40 | +2,048% |
Athira Pharma Inc Stock (ATHA) Price Forecast for 2030
Athira Pharma Inc Stock (ATHA) is expected to reach an average price of $11.91 in 2030, with a high forecast of $15.81 and a low forecast of $8.0025. This signifies an +1,967% surge from the last price of $0.576.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.5525 | $8.0025 | $11.57 | +1,211% |
| February, 2030 | $10.01 | $8.8347 | $8.6114 | +1,638% |
| March, 2030 | $10.54 | $11.00 | $10.62 | +1,730% |
| April, 2030 | $10.60 | $10.73 | $10.25 | +1,740% |
| May, 2030 | $15.07 | $15.32 | $15.81 | +2,516% |
| June, 2030 | $14.06 | $14.31 | $14.77 | +2,341% |
| July, 2030 | $13.78 | $14.14 | $14.11 | +2,292% |
| August, 2030 | $13.70 | $13.79 | $13.56 | +2,278% |
| September, 2030 | $12.86 | $12.89 | $13.20 | +2,132% |
| October, 2030 | $12.37 | $12.63 | $12.64 | +2,047% |
| November, 2030 | $11.85 | $11.97 | $12.03 | +1,957% |
| December, 2030 | $10.89 | $11.23 | $11.58 | +1,790% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):